The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•6 May 2026•

1 min read

Functional Brands Launches GLP-Squared Dual-Peptide Weight Loss Injection

Key Facts

1Functional Brands Inc. announced the launch of GLP-Squared, a dual-peptide injection combining Semaglutide and Tirzepatide.

2The new product is available exclusively to members of the company's Tru2u.health digital platform.

Functional Brands Inc. has officially announced the launch of GLP-Squared, a pioneering dual-peptide injection that combines Semaglutide and Tirzepatide into a single formulation. This new product is designed to offer a synergistic approach to weight management by leveraging the strengths of two of the most prominent peptides in the industry. The injectable will be offered exclusively to members of the company's proprietary digital health platform, Tru2u.health. By integrating this treatment into its digital ecosystem, Functional Brands aims to capture a significant share of the rapidly expanding weight-loss market. This strategic move highlights the company's focus on innovative biotech solutions and personalized wellness. The launch is expected to strengthen the company's position within the high-growth GLP-1 sector.